XML 29 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings per Share (Notes)
9 Months Ended
Oct. 28, 2017
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
 
We compute our basic earnings per share based on the weighted-average number of common shares outstanding and our diluted earnings per share based on the weighted-average number of common shares outstanding adjusted by the number of additional shares that would have been outstanding had potentially dilutive common shares been issued. Potentially dilutive securities include stock options, nonvested share awards and shares issuable under our employee stock purchase plan. Nonvested market-based share awards and nonvested performance-based share awards are included in the average diluted shares outstanding for each period, if established market or performance criteria have been met at the end of the respective periods.

The following table presents a reconciliation of the numerators and denominators of basic and diluted earnings per share from continuing operations for the three and nine months ended October 28, 2017, and October 29, 2016 ($ and shares in millions, except per share amounts):
 
Three Months Ended
 
Nine Months Ended
 
October 28, 2017
 
October 29, 2016
 
October 28, 2017
 
October 29, 2016
Numerator
 

 
 

 
 
 
 
Net earnings from continuing operations
$
238

 
$
192

 
$
635

 
$
600

 
 
 
 
 
 
 
 
Denominator
 
 
 
 
 
 
 
Weighted-average common shares outstanding
299.1

 
316.2

 
304.1

 
320.2

Dilutive effect of stock compensation plan awards
6.3

 
3.8

 
6.5

 
3.4

Weighted-average common shares outstanding, assuming dilution
305.4

 
320.0

 
310.6

 
323.6

 
 
 
 
 
 
 
 
Net earnings per share from continuing operations
 
 
 
 
 
 
 
Basic
$
0.80

 
$
0.61

 
$
2.09

 
$
1.87

Diluted
$
0.78

 
$
0.60

 
$
2.05

 
$
1.85



The computation of weighted-average common shares outstanding, assuming dilution, excluded options to purchase zero shares and 6.3 million shares of common stock for the three months ended October 28, 2017, and October 29, 2016, respectively, and options to purchase zero shares and 6.9 million shares of common stock for the nine months ended October 28, 2017, and October 29, 2016, respectively. These amounts were excluded as the options’ exercise prices were greater than the average market price of our common stock for the periods presented, and, therefore, the effect would be anti-dilutive (i.e., including such options would result in higher earnings per share).